Abstract
This study aims to test the predictive power of gene expression data derived from NIHs database dbEST, which collects gene expression results from a large number and variety of DNA array experiments. The motivation of this study is to make comparable experimental studies, which are usually performed only for one or a few tissues or organs, with a wide variety of other tissues. Confirmation of a good predictive power of dbEST would put a number of interesting and partially surprising recent findings, solely based on data mining, on a more solid basis than available so far. The expression of nine genes (eIF4E, DDX6, HAT1, USP28, HSP90β, PKM2, PLK1, COX2 and OPN) plus two calibration genes in paired normal and cancer colon tissues of eight individual patients was investigated by quantitative RT-PCR and compared with the predictions made by the data - base. GUS and β-actin reveal only little variation among different patients, making them good internal calibration standards. In normal colon tissue, data mining correctly predicts the expression of all nine genes, which covers two orders of magnitude. In cancer, dbEST is somewhat less precise, but still valuable for the comparison with clinical results.
Keywords: Gene Expression, Colon, Cancer Patients, dbEST, Osteopontin (OPN), Cyclooxygenase 2 (COX2), Histone acetyl transferase
Current Pharmaceutical Biotechnology
Title: The Database dbEST Correctly Predicts Gene Expression in Colon Cancer Patients
Volume: 9 Issue: 6
Author(s): M. Radeva, T. Hofmann, B. Altenberg, H. Mothes, K. K. Richter, B. Pool-Zobel and K. O. Greulich
Affiliation:
Keywords: Gene Expression, Colon, Cancer Patients, dbEST, Osteopontin (OPN), Cyclooxygenase 2 (COX2), Histone acetyl transferase
Abstract: This study aims to test the predictive power of gene expression data derived from NIHs database dbEST, which collects gene expression results from a large number and variety of DNA array experiments. The motivation of this study is to make comparable experimental studies, which are usually performed only for one or a few tissues or organs, with a wide variety of other tissues. Confirmation of a good predictive power of dbEST would put a number of interesting and partially surprising recent findings, solely based on data mining, on a more solid basis than available so far. The expression of nine genes (eIF4E, DDX6, HAT1, USP28, HSP90β, PKM2, PLK1, COX2 and OPN) plus two calibration genes in paired normal and cancer colon tissues of eight individual patients was investigated by quantitative RT-PCR and compared with the predictions made by the data - base. GUS and β-actin reveal only little variation among different patients, making them good internal calibration standards. In normal colon tissue, data mining correctly predicts the expression of all nine genes, which covers two orders of magnitude. In cancer, dbEST is somewhat less precise, but still valuable for the comparison with clinical results.
Export Options
About this article
Cite this article as:
Radeva M., Hofmann T., Altenberg B., Mothes H., Richter K. K., Pool-Zobel B. and Greulich O. K., The Database dbEST Correctly Predicts Gene Expression in Colon Cancer Patients, Current Pharmaceutical Biotechnology 2008; 9 (6) . https://dx.doi.org/10.2174/138920108786786330
DOI https://dx.doi.org/10.2174/138920108786786330 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Tumor Suppressor Gene ARF as a Sensor of Oxidative Stress
Current Molecular Medicine Propofol Pretreatment Prevents Oxygen-Glucose Deprivation/Reoxygenation (OGD/R)-induced Inflammation Through Nuclear Transcription Factor κB (NF-κB) Pathway in Neuroblastoma Cells
Current Neurovascular Research Anti-tumor Effects of Curcuminoids in Glioblastoma Multiforme: An Updated Literature Review
Current Medicinal Chemistry Lateral Flow Assay for Interleukin 6: A Technological and Scientific Prospection of a 10-Year Survey
Recent Patents on Biotechnology Neurological Aspects of Grief
CNS & Neurological Disorders - Drug Targets Potential Cancer Gene Therapy by Baculoviral Transduction
Current Gene Therapy Statins in Aortic Disease
Current Pharmaceutical Design Stem Cells in Stroke Repair: Current Success & Future Prospects
CNS & Neurological Disorders - Drug Targets Novel Functionalization for Maximizing Cell Turnover from Microcarrier
Current Biotechnology Antiviral Profile of HIV Inhibitors in Macrophages: Implications for Therapy
Current Topics in Medicinal Chemistry Genetics and Gene Therapy of Anderson-Fabry Disease
Current Gene Therapy Editorial [Hot Topic: Regulation of Pathogenetic Aspects of Allergic Diseases (Guest Editor: Lydie Izakovicova Holla)]
Current Drug Targets - Inflammation & Allergy Viral Product Trafficking to Mitochondria, Mechanisms and Roles in Pathogenesis
Infectious Disorders - Drug Targets General Molecular Biology and Architecture of Nuclear Receptors
Current Topics in Medicinal Chemistry Intraperitoneal Drug Therapy: An Advantage
Current Clinical Pharmacology Analgesic Effects of Huwentoxin-IV on Animal Models of Inflammatory and Neuropathic Pain
Protein & Peptide Letters The Role of Amitriptyline in the Management of Non-small Cell Lung Cancer
Current Cancer Therapy Reviews Biological Relevance of Lysophospholipids and Green Solutions for Their Synthesis
Current Organic Chemistry The Treatment Targets of Asthma: From Laboratory to Clinic
Inflammation & Allergy - Drug Targets (Discontinued) Angiotensin II in Type 2 Diabetes Mellitus
Current Protein & Peptide Science